LPCN
NASDAQ
$2.15
Lipocine Inc (LPCN)
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceuticals for the treatment of metabolic and endocrine disorders. The company is headquartered in Salt Lake City, Utah.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $6 (+179.07%)
Market Cap
$18M
P/B Ratio
0.85
Free Cash Flow Yield
-56.96%
Beta (5Y)
0.73
Price Chart
Valuation
Market Cap$18M
Forward P/E5.64
P/S9.51
P/B0.85
Profitability
Total Revenue (TTM)$2M
Gross Profit (TTM)$2M
EBITDA-$12M
Operating Margin-3224%
EPS-$1.87
Financial Health
Free Cash Flow Yield-56.96%
Growth & Risk
EPS 5Y CAGR-16.53%
FCF 5Y CAGR-8.87%
Beta (5Y)0.73
Sharpe Ratio0.53